Top Buy
| Security ▲ | Buy | Sell | Buy (1M) | Sell (1M) | Price | Target price | Potential |
|---|---|---|---|---|---|---|---|
| Avadel Pharmaceuticals plc ADR | 1 | 0 | 0 | 0 | €15.10 | €23.00 | 52.318% |
| Aveo Pharmaceuticals Inc. | 1 | 0 | 0 | 0 | €13.85 | €100.00 | 622.022% |
| Avid Bioservices Inc | 2 | 0 | 1 | 0 | €7.15 | €8.75 | 22.378% |
| Axonics Modulation Technologies Inc | 9 | 0 | 0 | 0 | €62.00 | €66.53 | 7.305% |
| Axsome Therapeutics Inc | 2 | 0 | 0 | 0 | €69.04 | €100.00 | 44.844% |
| Bastide Le Confort | 1 | 0 | 1 | 0 | €18.02 | - | - |
| Bausch Health Companies Inc. | 3 | 0 | 1 | 0 | €7.50 | €16.47 | 119.657% |
| Baxter International | 3 | 0 | 0 | 0 | €34.05 | €48.16 | 41.463% |
| Bayer AG | 15 | 1 | 0 | 0 | €28.23 | €50.00 | 77.148% |
| Becton, Dickinson & Co. | 8 | 0 | 0 | 0 | €218.30 | €262.02 | 20.029% |
| BeiGene Ltd ADR | 8 | 1 | 1 | 0 | €150.00 | €255.89 | 70.593% |
| Biocryst Pharmaceuticals | 8 | 0 | 1 | 0 | €4.29 | €10.96 | 155.262% |
| Biogen Inc. | 44 | 2 | 4 | 1 | €199.50 | €293.57 | 47.154% |
| BioMarin Pharmaceutical Inc. | 20 | 0 | 3 | 0 | €77.98 | €102.62 | 31.597% |
| Bio-Techne Corp. | 10 | 0 | 2 | 0 | €70.50 | €75.80 | 7.522% |
| Blueprint Medicines Corp | 1 | 0 | 1 | 0 | €101.60 | - | - |
| Boston Scientific | 46 | 0 | 13 | 0 | €66.50 | €72.96 | 9.709% |
| Brainstorm Cell | 1 | 0 | 0 | 0 | €0.37 | - | - |
| Brookdale Sr Lvg | 2 | 0 | 1 | 0 | €6.40 | €8.27 | 29.263% |
| Bruker Corp. | 7 | 1 | 0 | 1 | €66.00 | €85.68 | 29.825% |
| Canopy Growth Corp | 4 | 0 | 0 | 0 | €0.47 | €1.75 | 273.134% |
| Cara Therapeutics Inc. | 8 | 1 | 1 | 0 | €0.72 | €4.63 | 545.649% |
| Catalent Inc. | 2 | 0 | 0 | 0 | €52.32 | €55.00 | 5.122% |
| Catalyst Pharmaceutical Partners Inc | 10 | 0 | 0 | 0 | €14.21 | €23.46 | 65.122% |
| Celldex Therapeutics | 9 | 1 | 0 | 0 | €37.20 | €51.20 | 37.627% |